N@N

Market Maker Surveillance Report. NLY, PFE, CX, ILNS, AGNC, FB, Highest Net Sell Volume and Negative Price Friction For Tuesda

August 7, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 3959 companies with "abnormal" market making, 3406 companies with positive Friction Factors and 1951 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Tuesday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Annaly Capital Management Inc (NYSE:NLY), Pfizer Inc (NYSE:PFE), Cemex SAB de CV (NYSE:CX), INTELLECT NEUROSCIENCES INC (OTC:ILNS), American Capital Agency Corp (NASDAQ:AGNC), Facebook Inc (NASDAQ:FB). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  NLY     $-0.150   -0.89%    9,605,662    32.59%    10,956,814   37.17%    -1,351,152   -90,077 
  PFE     $-0.510   -2.10%    13,930,965   25.26%    21,686,227   39.32%    -7,755,262   -152,064
  CX      $-0.140   -1.90%    1,852,361    25.50%    2,540,831    34.97%    -688,470     -49,176 
  ILNS    $-0.016   -63.56%   3,691,696    42.44%    5,006,631    57.56%    -1,314,935   -837,538
  AGNC    $-1.110   -3.26%    14,735,880   47.24%    15,610,209   50.05%    -874,329     -7,877  
  FB      $-1.290   -5.89%    17,168,856   48.22%    18,200,514   51.12%    -1,031,658   -7,997  

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have low price friction combined with more selling than buying (negative Net Volume) in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows NLY down $-0.15000 with a Friction Factor of -90,077 and a Net Volume of -1,351,152. That means that it takes 90,077 more shares of selling than buying to drop NLY by one penny. On Monday the Market Makers allowed the stock to move down on heavier selling than buying (low negative friction).

Annaly Capital Management Inc (NYSE:NLY) - Annaly Capital Management, Inc., a real estate investment trust, engages in the ownership, management, and financing of a portfolio of investment securities. The company invests primarily in mortgage pass-through certificates, collateralized mortgage obligations, agency callable debentures, and other mortgage-backed securities representing interests in or obligations backed by pools of mortgage loans. Annaly Capital also invests in Federal Home Loan Bank, Federal Home Loan Mortgage Corporation, and Federal National Mortgage Association debentures. The company has elected to be taxed as a real estate investment trust (REIT). As a REIT, the company would not be subject to federal corporate income tax, provided it distributes at least 90% of its taxable income to its stockholders. It was formerly known as Annaly Mortgage Management, Inc. and changed its name to Annaly Capital Management, Inc. in August 2006. Annaly Capital Management was incorporated in 1996 and is based in New York City.

Pfizer Inc (NYSE:PFE) - Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. The company's Biopharmaceutical segments provides Lipitor for elevated LDL-cholesterol levels in the blood; Enbrel for rheumatoid arthritis, polyarticular juvenile rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis; Lyrica for post-herpetic neuralgia, diabetic peripheral neuropathy, fibromyalgia, neuropathic pain, adjunctive treatment of epilepsy, and general anxiety disorder, as well as for use as an adjunctive therapy for adult patients with partial onset seizures; Prevnar/Prevenar for invasive pneumococcal disease; Celebrex for osteoarthritis and rheumatoid arthritis, and acute pain; Viagra for erectile dysfunction; Xalabrands for reducing elevated eye pressure; Effexor XR for depressive, generalized anxiety, social anxiety, and panic disorders; and Norvasc for hypertension. It also offers Zyvox for gram-positive pathogens; Premarin for menopausal symptoms; Sutent for renal cell carcinoma; Geodon/Zeldox for schizophrenia; Detrol/Detrol LA for overactive bladder; Zosyn/Tazocin, an intravenous antibiotic; Genotropin for growth hormone deficiency; Vfend, an antifungal agent; and Protonix for gastroesophageal reflux disease; Chantix/Champix for aid smoking cessation; BeneFIX, ReFacto AF, and Xyntha for lifelong bleeding disorder; Caduet for cardiovascular events; Revatio for pulmonary arterial hypertension; Pristiq for depressive disorder; Aricept for Alzheimers disease; and Spiriva for breathing problems. The companys Diversified segment offers animal health products, such as vaccines, anti-infectives, anti-inflammatories, antiemetics, and parasiticides; consumer healthcare products, such as dietary supplements, pain management, respiratory, and personal care; nutrition products; and gelatin, liquid, softgel, non-animal, and fish gelatin capsules. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Cemex SAB de CV (NYSE:CX) - CEMEX, S.A.B. de C.V., through its subsidiaries, engages in the production, marketing, distribution, and sale of cement, ready-mix concrete, aggregates, and other construction materials. It sells its products primarily to distributors in the construction industry. The company has operations in North America, Europe, South America, Central America, the Caribbean, Africa, the Middle East, and Asia. CEMEX, S.A.B. de C.V. was founded in 1906 and is based in Garza Garcia, Mexico.

INTELLECT NEUROSCIENCES INC (OTC:ILNS) - Intellect Neurosciences, Inc., a biopharmaceutical company, engages in the research and development of proprietary drug candidates for the treatment of Alzheimers disease and other diseases associated with oxidative stress. The companys drugs are based on its immunotherapy platform technologies, ANTISENILIN and RECALL-VAX. Its product candidates include IN-N01, a monoclonal antibody to prevent the accumulation and toxicity of the beta amyloid toxin; and OXIGON, a small molecule that targets the underlying pathology of the disease through a dual mode of action having anti-oxidant and anti-fibrilogenic activity. The company also involves in identifying drug candidates based on its RECALL-VAX technology, which uses chimeric peptides as vaccines to immunize patients with Alzheimers disease or individuals, who are susceptible to developing the disease because of age or other risk factors. It has a license agreement with AHP MANUFACTURING BV for the research, development, manufacture, and commercialization of therapeutic products for the treatment of Alzheimers disease. The company was founded in 2005 and is headquartered in New York, New York.

American Capital Agency Corp (NASDAQ:AGNC) - American Capital Agency Corp. (AGNC) operates as a real estate investment trust (REIT). It invests in agency pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government agency or a U.S. Government sponsored entities. The company funds its investments primarily through short-term borrowings structured as repurchase agreements. It has elected to be taxed as a REIT under the Internal Revenue Code of 1986. As a REIT, the company would not be subject to U.S. federal or state corporate taxes on its taxable net income to the extent that the company distributes its annual taxable net income to its stockholders. AGNC is externally managed and advised by American Capital Agency Management, LLC, a subsidiary of a wholly-owned portfolio company of American Capital, Ltd., an alternative asset manager included in the S&P 500. The company was founded in 2008 and is based in Bethesda, Maryland.

Facebook Inc (NASDAQ:FB) -

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net